DSM reported full year 2012 sales rising 9% to €726m, which the company attributed to increased volumes at DSM Pharmaceutical Products. DSM expects the business conditions for the pharma sector to remain challenging in 2013 but is confident of being able to deliver substantially better results during the year.
DSM
Wednesday, 20 February 2013
DSM pharma sales rise in 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment